Land Cress (Barbarea verna): A Comprehensive Reference
1. Identity, Taxonomy, and Nomenclature
Botanical Classification
Barbarea verna is a biennial herb in the family Brassicaceae. It is diploid with a chromosome number of 2n=16, and phylogenetically it resides within the monophyletic genus Barbarea of the tribe Cardamineae in Brassicaceae, forming part of the Cardamine clade alongside genera like Cardamine and Nasturtium, with close relations to other edible cresses. The species carries numerous taxonomic synonyms, including the homotypic synonyms Campe verna (Mill.) A.Heller and Erysimum vernum Mill., as well as heterotypic synonyms such as Barbarea praecox (Sm.) R.Br., Barbarea brevistyla Jord., Barbarea longisiliqua Jord., and Barbarea patula Fr.
Common Names
Common names include land cress, American cress, bank cress, black wood cress, Belle Isle cress, Bermuda cress, poor man's cabbage, early yellowrocket, early wintercress, scurvy cress, creasy greens, and upland cress. The diversity of names reflects both the plant's broad geographic range and its long cultural importance as a food source across multiple traditions.
Etymology
The genus name Barbarea derives from Saint Barbara, the patron saint of artillerymen and miners, as this plant in the past was used to soothe the wounds caused by explosions. The species epithet verna is Latin for "of spring," reflecting the plant's early spring harvest window.
Botanical Description
An annual or biennial, winter-green herbaceous plant in the Brassicaceae, the seeds typically germinate in the autumn to form an over-wintering rosette. The following spring, it grows a main stem up to about 90 cm, sometimes up to 130 cm, which is pale green, grooved (sulcate) and occasionally branched. The leaves are alternate and pinnate with clasping auricles at the base and between 4 and 11 pairs of sub-opposite lobes. Bright yellow 4-petaled flowers grow in racemes with elongating, ascending siliques and a short beak. Land cress is considered a satisfactory substitute for watercress.
Native Range and Naturalization
Barbarea verna is native to southwestern and southern Europe, ranging from the Azores and Portugal through France, Spain, Corsica, Sardinia, and Italy. Its distribution extends eastward to western Asia, including southwestern Turkey. The species occupies primarily Mediterranean to temperate climatic zones across these regions. It has been introduced and naturalized in several regions outside its native European range, primarily through human-mediated dispersal as a cultivated edible green. In North America, it was brought by European settlers for its use as a leafy vegetable, escaping cultivation to become widespread throughout the United States and parts of Canada. Beyond North America, B. verna was introduced to Australia around 1910, where it is naturalized in temperate regions.
Common Forms and Preparations
Land cress is available primarily as a fresh leafy vegetable and is consumed in several forms. Upland cress is best suited for both raw and cooked applications such as steaming, boiling, or sautéing. Edible parts include the leaves, oil, and seed. The plant has also attracted interest as a potential oilseed crop: research has shown that the plant, with its winter hardiness, relatively large seeds, and high seed yields, has the potential to become a new oilseed crop. In dietary supplement contexts, extracts prepared from the seeds have been used specifically as a concentrated source of its principal glucosinolate. The isolation of gram-amounts of 2-phenylethyl glucosinolate (gluconasturtiin, GST) from Barbarea verna seeds has been reported; this vegetable source was of crucial importance to isolate GST with a high purity grade and in high yield.
2. Traditional and Historical Use
European Tradition
Land cress has been cultivated as a leaf vegetable in England since the 17th century. It is a biennial herb indigenous to Europe, where it has been a preferred salad plant since the 16th century. As it requires less water than watercress, it is easier to cultivate. Throughout the early modern period in England and continental Europe, land cress served as an inexpensive, cold-hardy green that could be harvested during late winter and early spring when other fresh vegetables were unavailable. This seasonal role made it a practical dietary supplement for populations at risk of vitamin deficiency during winter months.
Historically, it was valued for its nutrient density, particularly its high vitamin C content, which made it a vital remedy against scurvy during times when other fresh greens were scarce. Its peppery flavor was also believed to stimulate digestion, and traditional herbalists often recommended it to support liver function and to promote detoxification. The common name "scurvy cress" directly reflects this historical use as an anti-scorbutic food.
A similar named variety, 'Belle Isle,' earned its name by staving off scurvy in a group of shipwrecked sailors who spent an unfortunate winter on the aforementioned island.
Appalachian and North American Tradition
"Creasy sallet" or creasy greens — the cooked leaves of upland (or land) cress — became a traditional food in Appalachia. This plant, native to Eurasia, had been cultivated in England since the 1600s, after which it became naturalized and cultivated in North America. Barbarea species have been used in Europe and the United States as "creasy greens," a staple in early American and Appalachian diets, where they were gathered from wild or garden patches to flavor soups and stews during scarce winter months. The leaves have a peppery flavor and can be eaten fresh, cooked in stews, or sautéed. A typical Appalachian preparation involved the latter, cooked in pork fat.
Use as a Wound Herb
The genus name 'Barbarea' is derived from the early Greek Saint Barbara, the patron saint of artillerymen and miners, and this plant was used to soothe the wounds caused by explosions. This traditional wound application is corroborated by the genus-level etymology and represents one of the older recorded medicinal uses of plants in the Barbarea genus in European tradition.
South Asian Ethnobotanical Record
A field ethnobotanical survey (2020–2021) documented Barbarea verna among the wild food plants recorded from the Kohistan region of Upper Khyber Pakhtunkhwa, Pakistan. Food ingredients from Barbarea verna were noted as new to the food ethnobotanical literature of Pakistan at the time of the survey. This finding suggests that the plant's use as a food extends beyond its European and North American range, with regional populations in the mountainous areas of South Asia also foraging it as a seasonal wild vegetable.
3. Key Constituents and Active Compounds
Glucosinolates: Gluconasturtiin (2-Phenylethyl Glucosinolate)
The most pharmacologically significant phytochemicals in land cress are glucosinolates — sulfur-containing secondary metabolites characteristic of the Brassicaceae family. The isolation of gram-amounts of 2-phenylethyl glucosinolate (gluconasturtiin, GST) from Barbarea verna seeds is reported, and this vegetable source was of crucial importance to isolate GST with a high purity grade and in high yield. B. verna seeds contain GST as the only glucosinolate, unlike other sources. This chemical simplicity — a single dominant glucosinolate — makes B. verna seeds particularly valuable as a research material.
2-Phenylethyl glucosinolate (gluconasturtiin) is biosynthesized and stored in vegetative and reproductive tissues of some Brassica species. GST is hydrolysed into bioactive phenylethyl isothiocyanate (PEITC) by the endogenous enzyme myrosinase, which is released from separate cellular compartments only when cells are damaged either by chewing or through food preparation. This myrosinase-glucosinolate system is the fundamental activation mechanism underlying the biological activity of this compound.
Phenylethyl Isothiocyanate (PEITC): The Primary Bioactive Hydrolysis Product
Phenylethyl isothiocyanate (PEITC) is one such promising cancer chemopreventive agent abundant in edible cruciferous vegetables. Gluconasturtiin, one of the predominant glucosinolates in cruciferous vegetables, is hydrolyzed to yield phenylethyl isothiocyanate (PEITC). PEITC absorption and metabolism in humans involves glutathione conjugation followed by conversion via the mercapturic acid pathway to an N-acetylcysteine (NAC) conjugate that is excreted in the urine.
Triterpenoid Saponins
One class of secondary metabolites present in the Barbarea genus is triterpenoid saponins. A few species in the Barbarea genus produce saponins as the only ones in the large crucifer family. Research on the closely related Barbarea vulgaris has characterized these compounds in detail: four triterpenoid saponins — hederagenin cellobioside, oleanolic acid cellobioside, epihederagenin cellobioside, and gypsogenin cellobioside — have been identified and correlated with resistance of plants against insect herbivores. Additionally, research has confirmed phytoalexins specific to the Barbarea genus: a 2015 study (Pedras, Alavi, and To) reported that nasturlexins C and D and their sulfoxides are phytoalexins of the crucifers Barbarea vulgaris and B. verna.
Vitamins and Minerals
Land cress is nutritionally dense relative to its caloric content. Upland cress contains vitamins A, C, and K, vitamin B2, potassium, iron, folate, manganese, and calcium. The vitamin C content has been of particular historical importance: the name "scurvy cress" reflects traditional recognition of this property. Creasy greens are nutritious, high in vitamin C, and grow in late winter in many places, providing much-needed nutrition.
Glucosinolate Content in Context of the Brassicaceae Family
Brassica vegetables are a rich source of sulfur compounds, such as glucosinolates (GLSs) and isothiocyanates (ITCs), which provide health benefits but are also suspected of having a goitrogenic effect. The average amount of total GLSs in leafy vegetables ranges from 10–110 mg/100 g fresh weight. Land cress is distinguished by the relative purity of its glucosinolate profile — dominated by gluconasturtiin in the leaves and seeds — which simplifies its use as a research and extraction source. Several known GSLs have been isolated in pure form from Brassicaceae seeds, including gluconasturtiin from Barbarea verna.
4. Established Mechanisms of Action
Myrosinase–Glucosinolate Activation System
When vegetables are ingested, isothiocyanates (ITCs) are liberated through the hydrolysis of glucosinolates either by myrosinase that is released when vegetables are chewed, or by microflora in the intestinal tract. This two-compartment enzymatic system is the central mechanism by which gluconasturtiin in land cress is converted to its bioactive form, PEITC, upon mechanical disruption of plant cells.
Cytochrome P450 Inhibition and Phase I Enzyme Modulation
The inhibitory effects of PEITC on cytochrome P450 enzymes including human P450s 2A13, 2A6, 1A2, and 2B6 are well established; these enzymes are catalysts of NNK (a tobacco-specific carcinogen) bioactivation. PEITC is metabolized by glutathione S-transferase (GST) in the liver, with the glutathione conjugate undergoing further conversion to mercapturic acid. PEITC modulates the activity and expression of numerous phase I and phase II drug-metabolizing enzymes and can inhibit the metabolism of procarcinogens to form carcinogens.
Phase II Enzyme Induction and Glutathione Pathway
Glutathione S-transferases (GST) catalyze the conjugation of carcinogens and toxicants with glutathione, enhancing their urinary excretion; functional GST genotypes may modify the effect of PEITC. Induction of detoxification enzymes — a key chemopreventive mechanism shared across isothiocyanates from cruciferous vegetables — facilitates the elimination of reactive carcinogens before they can form DNA adducts.
Modulation of Cancer Cell Signaling Pathways
PEITC targets crucial cellular signaling pathways involved in cancer progression, notably the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB), Protein Kinase B (Akt), and Mitogen-Activated Protein Kinase (MAPK) pathways. Studies in human cancer cell lines have established additional mechanistic detail: PEITC exerted an inhibitory effect on SOS-1, PKC, ERK1/2, and RhoA, causing inhibitions of MMP-2 and -9, and also affected Ras, FAK, PI3K, and inhibited GRB2, NF-κB, iNOS, and COX-2, causing inhibition of cell proliferation in colon cancer cells.
Cell Cycle Arrest and Apoptosis Induction
An inhibitory effect of PEITC and its metabolite NAC-PEITC on cancer cell proliferation, cell-cycle progression, and apoptosis has been observed in LNCaP human prostate cancer cells. PEITC and NAC-PEITC suppressed LNCaP cell proliferation in a dose-dependent manner, and exposure to 5 µM PEITC or NAC-PEITC reduced cell proliferation by 25% and 30%, respectively. Cell-cycle analysis revealed that cells treated with these concentrations arrested at the G(2)/M phase.
Pharmacokinetics of PEITC
Pharmacokinetic features of unchanged PEITC include linear and first-order absorption, high protein binding and capacity-limited tissue distribution, and reversible metabolism and capacity-limited hepatic elimination. Membrane transport of PEITC is mediated by BCRP, multidrug resistance-associated protein (MRP) 1, and MRP2 transporters belonging to the ATP-binding-cassette (ABC) family.
5. Scientific Evidence by Area of Use
5a. Cancer Chemoprevention — Lung Cancer
Preclinical Evidence (Animal Models): Extensive preclinical work established PEITC's anti-carcinogenic activity in rodent models. Studies have shown that dietary administration of PEITC significantly reduces tumor incidence induced by NNK and benzo(a)pyrene (BaP) in mouse models. These agents are major carcinogens of tobacco smoke. PEITC inhibits lung tumor induction by NNK in F-344 rats and A/J mice. PEITC selectively inhibits metabolic activation of NNK in the rodent lung, while inducing glucuronidation of NNAL, one of the major NNK metabolites. Thus, PEITC decreases DNA and hemoglobin adduct formation by NNK while increasing the amounts of NNAL and its glucuronide excreted in the urine.
Human Clinical Evidence: A randomized crossover clinical trial enrolled 82 smokers. Overall, the NNK metabolic activation ratio was reduced by 7.7% with PEITC treatment (P = 0.023). The results of this trial, while modest in effect size, provide a basis for further investigation of PEITC as an inhibitor of lung carcinogenesis by NNK in smokers. During the one-week treatment period, each subject took PEITC (10 mg in 1 mL of olive oil, 4 times per day, totalling 40 mg/day). A Phase 2 randomized trial subsequently confirmed and extended these findings: the results of this trial demonstrate that PEITC inhibits the metabolic activation of NNK in smokers, and has a stronger effect on the detoxification of environmental carcinogens and toxicants such as benzene, acrolein, and crotonaldehyde. A more pronounced effect of PEITC was observed in subjects lacking both GSTM1 and GSTT1 genes, supporting the epidemiological findings of stronger protection of dietary isothiocyanates against the development of lung cancer in such individuals.
Evidence Strength: The clinical evidence for PEITC's ability to modulate NNK metabolism in smokers is statistically significant but modest in absolute effect size. These trials are biomarker-based surrogate endpoint studies, not long-term cancer incidence trials. The finding that PEITC reduces NNK metabolic activation by approximately 7.7–8% in smokers is biologically plausible but requires confirmation in longer trials with hard clinical endpoints.
5b. Cancer Chemoprevention — Prostate Cancer
Preclinical Evidence: In vivo chemopreventive efficacy of PEITC against prostate cancer has been established in a transgenic mouse model (TRAMP model). Feeding of 3 µmol PEITC/g diet significantly decreased incidence as well as burden of poorly differentiated cancer in the dorsolateral prostate of TRAMP mice. Evidence for a protective effect of cruciferous vegetables and their components, including PEITC, against prostate cancer derives from population-based observational studies as well as laboratory investigations. For example, a population-based case-control study suggested an inverse association between intake of cruciferous vegetables and the risk of prostate cancer.
Mechanistic (Cell Line) Evidence: PEITC treatment activates Notch signaling in malignant as well as normal human prostate cells. Exposure of human prostate cancer cells (LNCaP, PC-3, and DU145) and a normal human prostate epithelial cell line (PrEC) to PEITC resulted in cleavage (active form) of Notch1 and Notch2, and increased transcriptional activity of Notch.
Evidence Strength: Evidence is strong at the preclinical (rodent and cell culture) level. Epidemiological associations are suggestive but indirect, relying on cruciferous vegetable intake generally rather than on land cress or PEITC specifically. No dedicated clinical trials of PEITC for prostate cancer outcomes have been completed as of the available literature.
5c. Cancer Chemoprevention — Colon Cancer
Cell Line Evidence: PEITC induced a cytotoxic effect (decreased the percentage of viable cells) in human colon cancer HT29 cells, and its antimetastatic effect in HT29 human colon cancer cells has been reported. PEITC exhibited an inhibitory effect on the abilities of adhesion, migration, and invasion of these cells.
Evidence Strength: Preliminary; in vitro only. No human clinical trials specifically testing PEITC in colon cancer have been reported in the available literature.
5d. Cancer Chemoprevention — Breast Cancer
Mechanistic Evidence: PEITC treatment produced significant alterations in genes involved in tumor suppression and cellular proliferation/apoptosis, which may be important in explaining the chemopreventive effects of PEITC in breast cancer cells. Inhibition of angiogenesis is one of the recently reported mechanisms of breast cancer prevention by PEITC.
Evidence Strength: Gene expression and cell culture studies only. No dedicated human clinical trial data specific to breast cancer outcomes were found in the available literature.
5e. Scurvy Prevention and Vitamin C Nutrition
The historical use of land cress against scurvy is well-documented and is scientifically coherent with its known vitamin C content. It was valued for its nutrient density, particularly its high vitamin C content, which made it a vital remedy against scurvy during times when other fresh greens were scarce. The role of vitamin C in preventing and treating scurvy is established biomedical science, and land cress has been recognized under the name "scurvy cress" precisely for this property. Creasy greens are nutritious, high in vitamin C, and grow in late winter in many places, providing much-needed nutrition. No land-cress-specific clinical trials for scurvy or vitamin C sufficiency were identified in the literature.
5f. Antioxidant Activity
As a member of Brassicaceae, land cress contains multiple antioxidant compounds including vitamin C, vitamin A precursors (carotenoids), and glucosinolate hydrolysis products. It contains antioxidants, which help protect cells from damage. Systematic characterization of the antioxidant capacity of Barbarea verna specifically (as opposed to glucosinolate-bearing Brassica vegetables generally) is limited in the peer-reviewed literature reviewed for this article. Evidence is largely inferential from shared compound classes.
5g. General Clinical Status of PEITC
Pre-clinical evidence suggests that combination of PEITC with conventional anti-cancer agents is also highly effective in improving overall efficacy. Based on accumulating evidence, PEITC appears to be a promising agent for cancer therapy and is already under clinical trials for leukemia and lung cancer. Further research is necessary to determine the optimal dosage, understand its bioavailability, and assess potential side effects, which will be crucial for developing PEITC-based treatments that are both effective and safe for clinical use in cancer therapy.
6. Body Systems and Health Areas Associated with Land Cress
- Oncology / Cancer Prevention: The primary area of active scientific research. PEITC derived from gluconasturtiin has been studied in human clinical trials for lung cancer chemoprevention and in preclinical models for prostate, colon, and breast cancer.
- Immune and Detoxification Systems: PEITC modulates the activity and expression of numerous phase I and phase II drug-metabolizing enzymes and can inhibit the metabolism of procarcinogens to form carcinogens and increase carcinogen elimination.
- Nutritional / Anti-Scorbutic: Vitamin C content historically relevant to scurvy prevention; vitamin K, folate, and other micronutrients relevant to bone metabolism and hematopoiesis.
- Digestive System: Traditional use included stimulation of digestion via the peppery constituents (glucosinolate hydrolysis products acting as irritant stimulants to gastric secretion). This is a traditional claim without direct clinical trial evidence specific to B. verna.
- Liver: Traditional herbalists recommended it to support liver function and to promote detoxification. The Phase I/II enzyme-modulating properties of PEITC provide a plausible biochemical basis for this traditional claim, though clinical evidence is lacking.
- Thyroid: As a glucosinolate-containing Brassica plant, potential goitrogenic effects fall within the safety profile of the compound class (see Section 8).
7. Dosage Forms and Reported Dosages
There are no pharmacopoeial monographs for Barbarea verna as a medicinal herb or dietary supplement. Dosages documented in the scientific literature relate specifically to PEITC, derived from gluconasturtiin, studied in clinical trials:
- Clinical trial dosage (lung cancer chemoprevention): Each subject took PEITC 10 mg in 1 mL of olive oil, 4 times per day (totalling 40 mg/day), over a one-week treatment period.
- Phase 2 randomized clinical trial: Intake of PEITC 40 mg/day for 5 days significantly inhibited NNK metabolic activation by 8% (P = 0.023) and increased urinary detoxification mercapturic acids formed from benzene by 25% (P = 0.002) and acrolein by 15% (P = 0.005), in 82 current smokers in the US.
- Prostate cancer animal model dosage: Feeding of 3 µmol PEITC/g diet significantly decreased incidence as well as burden of poorly differentiated cancer in the dorsolateral prostate of TRAMP mice. (Animal study; not directly translatable to human dosing.)
- Cell culture: Exposure to 5 µM PEITC or NAC-PEITC reduced LNCaP prostate cancer cell proliferation by 25% and 30%, respectively. (In vitro study; not directly translatable to human dosing.)
No standardized dosage for land cress leaf consumption as a dietary supplement has been defined in peer-reviewed clinical literature. The plant is consumed as a food vegetable without defined therapeutic dose ranges for specific indications.
8. Safety Considerations and Interactions
Goitrogenic Potential of Glucosinolates
The key active secondary metabolites in Brassica vegetables most often associated with antithyroid/goitrogenic effects are sulfur compounds: glucosinolates (GLSs) and their derivatives, such as isothiocyanates (ITCs) and thiocyanates. Following enzymatic breakdown, some glucosinolates in Brassica vegetables produce sulforaphane, phenethyl, and indolylic isothiocyanates that possess anticarcinogenic activity. In contrast, progoitrin and indolylic glucosinolates degrade to goitrin and thiocyanate, respectively, and may decrease thyroid hormone production.
Importantly, the dominant glucosinolate in B. verna seeds is gluconasturtiin, which yields PEITC rather than goitrin. Isothiocyanates' anti-thyroid effects are due both to their transformation into thiocyanate and their ability to react with amino groups and form thiourea derivatives, which are competitive inhibitors of the TPO activity. However, context matters: in practice, this is primarily a concern under two conditions: when someone eats very large amounts of raw cruciferous vegetables, and when iodine intake is already low. A diet containing a normal serving size of Brassicaceae (100–200 g of fresh weight) does not affect thyroid function.
Potential for Dual Effects of PEITC (Pre- vs. Post-Initiation)
One important and source-backed nuance concerning PEITC safety is its context-dependent carcinogenic/chemopreventive duality: PEITC treatment during the pre-initiation period caused reduced hyperplasia in esophagus and lungs accompanied with reduction of GSTP in kidney and liver. However, PEITC treatment during the post-initiation phase increased liver GSTP-positive foci along with increased incidence of urinary bladder hyperplasia and tumors. This suggests preventive effects of PEITC in preinitiation conditions, while during post-initiation, PEITC treatment may increase tumor incidence. This preclinical observation, while derived from high-dose animal studies, is a relevant safety signal for concentrated supplement use.
Drug-Metabolizing Enzyme Interactions
PEITC-mediated modulation of transporter proteins is an important factor for the chemopreventive effects of PEITC. Transporter proteins are important determinants of the efficacy and toxicity of many clinical drugs, and by modulating these proteins, PEITC can affect the efficacy as well as toxicity of some other drugs. Membrane transport of PEITC is mediated by BCRP, multidrug resistance-associated protein (MRP) 1, and MRP2 transporters belonging to the ATP-binding-cassette (ABC) family. These transporter interactions suggest a potential for PEITC to alter the pharmacokinetics of co-administered drugs that are substrates of these efflux transporters, though clinical interaction data specific to land cress as a food or supplement were not identified in the available literature.
Vitamin K Content and Anticoagulant Interactions
Land cress is a good source of vitamin K. Individuals taking blood-thinning medications should be mindful of their vitamin K intake due to its role in blood clotting. This is a class-wide interaction concern for all vitamin K–rich leafy greens consumed in therapeutic or supplement quantities alongside anticoagulant medications such as warfarin.
Cooking and Preparation Effects
Glucosinolates in Brassica vegetables can be hydrolyzed into various products, including chemopreventive isothiocyanates and the anti-thyroid substance goitrin. Cooking can reduce goitrin but also destroy isothiocyanates. This has practical relevance for consumers: raw consumption of land cress preserves PEITC-generating potential (as the enzyme myrosinase remains active), while cooking inactivates myrosinase and reduces isothiocyanate formation, though intestinal microflora can partially compensate for some glucosinolate hydrolysis in cooked vegetables.
General Safety Profile
Land cress has a centuries-long history of safe food consumption across multiple cultures without documented episodes of acute toxicity at dietary amounts. At food-based intakes, no significant adverse effects have been reported in the peer-reviewed literature reviewed here. Safety concerns are primarily relevant at pharmacological concentrations of PEITC (as in concentrated extracts or supplements) or in the specific population contexts noted above (iodine deficiency, concurrent drug therapy).
References
Go back